Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for user interaction while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference2%
- Check36 days agoChange DetectedSeveral key health-related websites, including MedlinePlus and DailyMed, have been removed from the monitored list, indicating a potential shift in focus or resource availability.SummaryDifference0.2%
- Check44 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to skin cancer and treatments like Cetuximab and Pembrolizumab, while removing the previous version 2.12.1.SummaryDifference3%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.